New Zealand vs United Kingdom of Great Britain and Northern Ireland: Hepatitis B surface antigen (HBsAg) prevalence
New Zealand
0.0%
in 2024
United Kingdom of Great Britain and Northern Ireland
0.0%
in 2024
New Zealand rank
132nd
United Kingdom of Great Britain and Northern Ireland rank
132nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- New Zealand
- United Kingdom of Great Britain and Northern Ireland
How they compare
New Zealand currently reports 0.0% against 0.0% in United Kingdom of Great Britain and Northern Ireland, a difference of 0.0%.
Across all 10 years both countries report, United Kingdom of Great Britain and Northern Ireland has been ahead every year.
New Zealand ranks 132nd and United Kingdom of Great Britain and Northern Ireland ranks 132nd of 194 countries.
Head to head by decade
| Decade | New Zealand | United Kingdom of Great Britain and Northern Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | — |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, New Zealand or United Kingdom of Great Britain and Northern Ireland?
- New Zealand, at 0.0% against 0.0% in United Kingdom of Great Britain and Northern Ireland as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between New Zealand and United Kingdom of Great Britain and Northern Ireland?
- 0.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and United Kingdom of Great Britain and Northern Ireland?
- 10 years are reported by both, from 2015 to 2024.
- How do New Zealand and United Kingdom of Great Britain and Northern Ireland rank globally for hepatitis b surface antigen (hbsag) prevalence?
- New Zealand ranks 132nd and United Kingdom of Great Britain and Northern Ireland ranks 132nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.